9th Annual IBA World Life Sciences Conference

31 May - 2 Jun 2023

Session information

Roundtables

Committee(s)

Healthcare and Life Sciences Law Committee (Lead)
Intellectual Property and Entertainment Law Committee (Lead)
Technology Law Committee (Lead)

Description

Topic one
Post-Covid-19 litigation trends

Moderators
James C Fraser Thompson Hine, Washington, DC
Beth Weinman Ropes & Gray, Washington, DC

Topic two
Responsibility, liability and conflict of interests: risks met by compliance officers

Moderators
Catherine Longeval Van Bael & Bellis, Brussels
Emily Mason Amgen, Los Angeles, California

Topic three
Evolution of product liability rules

Moderators
Eric Alexander  Reed Smith, Washington, DC 
Edona Vila Borden Ladner Gervais, Toronto, Ontario

Topic four
Evolution of telemedicine (survey conducted by the IBA Healthcare and Life Sciences Committee)

Moderators
Renata Fialho  Veirano, São Paulo
René Quashie Vice President, Digital Health, Consumer Technology Association, producer of CES®, Washington, DC

Topic five
Rare diseases and the continuous challenge of marketing an orphan drug

Moderators
David Parsons Leadiant Biosciences, Washington, DC
Kristin Wall Norton Rose, Toronto, Ontario

Topic six
Current opportunities and challenges in strategic collaborations

Moderators
Harry Rubin Kramer Levin, New York
Elysangela  De Oliveria Rabelo Maurer Rabelo Maurer, Brazil

Topic seven
The European unitary patent court system

Moderators
Christophe Ronse Altius, Brussels
Amrish Tiwari  KNS Partners, Gurgaon, Haryana

Topic eight
Post public health emergency

Moderator
Howard Sklamberg Arnold & Porter, Washington, DC

 

Topic nine
Patents in the US versus ROW

Moderators
Jason Jardine Knobbe Martens, San Diego, California
Alex Spiegler ArentFox Schiff, New York

Topic ten
Impact of metaverse on life sciences industry: fiction or future reality?

Moderators
Jeff Costellia Nixon Peabody, Washington, DC
Elisa Stefanini Portolano Cavallo, Milan

Topic eleven
Recent regulatory changes and opportunities in medical and recreational cannabis

Moderators
Ignacio Gillmore Carey, Santiago
Mariana Larrea Grupo Libera, Mexico City

Topic twelve
Public to private sector technology transfer: challenges and solutions

Moderator
Camila Parise Pinheiro Neto, São Paulo

Topic thirteen
Food labelling (octagons, symbols, difficulties) and cannabis regulations

Moderators
Ana Maria Castro Lloreda Camacho, Bogota
Viviana Cervieri Cervieri Monsuárez, Montevido

Topic fourteen
Managing market access at a global level

Moderators
Markus Schott Bär & Karrer, Zurich
Charlotte Tillett Stevens & Bolton, Guildford, Surrey, England

Topic fifteen
Pricing of medications

Moderators
Miranda Franco Holland & Knight, Washington, DC
Andreas Wildi Walder Wyss, Zurich

Topic sixteen
Abortion pill: medicine versus law

Moderators
John Murphy Chief Policy Officer, Biotechnology Innovation Organization, Washington, DC 
Eva Temkin King & Spalding, Washington, DC

Topic seventeen
How new players will impact traditional healthcare providers
 

Moderator
Gary Copelovitz  Lipa Meir & Co, Tel Aviv

Session / Workshop Chair(s)

Eric Lawrence Alexander Reed Smith LLP, Washington, District of Columbia, USA
Ana Maria Castro Lloreda Camacho & Co, Bogota, Colombia
Viviana Cervieri Cervieri Monsuárez, Montevideo, Uruguay
Gary Copelovitz Lipa Meir & Co, Tel Aviv, Israel
Jeffrey Costellia Nixon Peabody LLP, Washington, District of Columbia, USA; Website Officer, Intellectual Property and Entertainment Law Committee
Renata Fialho Veirano Advogados, São Paulo, Brazil; Latin American Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee
Miranda Franco Holland & Knight, Washington, District of Columbia, USA
James C Fraser Thompson Hine, Washington, District of Columbia, USA
Ignacio Gillmore Carey y Cia, Santiago, Chile
Yuval Horn Horn & Co, Tel Aviv, Israel; Member, Technology Law Committee Advisory Board
Jason Jardine Knobbe Martens Olson and Bear LLP, San Diego, California, USA; Chair, Patent Law Subcommittee
Mariana Larrea MLA Consulting / Legal Boutique, Toluca, Mexico
Catherine Longeval Van Bael & Bellis, Brussels, Belgium; Co-Chair, Healthcare and Life Sciences Law Committee
Emily Mason Amgen, Thousand Oaks, California, USA
John Murphy III Biotechnology Innovation Organization, Washington, District of Columbia, USA
Camila Parise Pinheiro Neto Advogados, São Paulo, Brazil
David Parsons Leadiant Biosciences, Washington, District of Columbia, USA
René Quashie Consumer Technology Association, Arlington, Virginia, USA
Elysangela Rabelo Rabelo Law, São Paulo, Brazil; Vice Chair, Life Sciences Subcommittee
Christophe Ronse Altius, Brussels, Belgium; Scholarship Officer, Intellectual Property and Entertainment Law Committee
Harry Rubin Kramer Levin, New York, New York, USA
Markus Schott Baer & Karrer, Zürich, Switzerland
Howard Sklamberg Arnold & Porter, Washington, District of Columbia, USA
Alex Spiegler Arent Fox Schiff LLP, New York, New York, USA
Elisa Stefanini Portolano Cavallo, Milan, Italy
Eva Temkin King & Spalding, Washington, District of Columbia, USA
Charlotte Tillett Stevens & Bolton, Guildford, England
Amrish Tiwari K&S Partners, New Delhi, Delhi, India; Chair, Life Sciences Subcommittee
Edona Vila Borden Ladner Gervais, Toronto, Ontario, Canada; Membership Officer, Product Law and Advertising Committee
Kristin Wall Norton Rose Fulbright, Toronto, Ontario, Canada
Beth Weinman Ropes & Gray, Washington, District of Columbia, USA
Andreas Wildi Walder Wyss Ltd, Bern, Switzerland